# aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation

Study · id `cardio:ct-nct02513797` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02513797](<https://clinicaltrials.gov/study/NCT02513797>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02513797

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.

## Technical summary

Registry record NCT02513797. Randomized; no masking; primary purpose treatment. Start 2015-09 (actual); primary completion 2021-04-21 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT02513797, source copy `cardio:ctgov-nct02513797-2021-09-05`, retrieved 2026-10-26)
- Started: 2015-09 (actual) (ClinicalTrials.gov record NCT02513797, source copy `cardio:ctgov-nct02513797-2021-09-05`, retrieved 2026-10-26)
- Primary completion: 2021-04-21 (actual) (ClinicalTrials.gov record NCT02513797, source copy `cardio:ctgov-nct02513797-2021-09-05`, retrieved 2026-10-26)
- Completion: 2022-03 (anticipated) (ClinicalTrials.gov record NCT02513797, source copy `cardio:ctgov-nct02513797-2021-09-05`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02513797, source copy `cardio:ctgov-nct02513797-2021-09-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02513797-2021-09-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
- Acronym: aMAZE
- Condition: Atrial Fibrillation
- Intervention (Device): LARIAT + PVI
- Intervention (Device): Pulmonary Vein Isolation
- Lead sponsor: AtriCure, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: AtriCure, Inc. (`cardio:org-atricure-inc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation: The aMAZE Randomized Clinical Trial (`cardio:pubmed-38563835`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Left Atrial Size and Volume Reduction on Pulmonary Vein Isolation Efficacy in Patients With Persistent and Longstanding Persistent Atrial Fibrillation: Subset Analysis From the aMAZE Trial (`cardio:pubmed-42517227`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4c20542e2811ed534c1a30b129ddc19ea8ce15b5f84439b2d9c6dbc9d1fdd63f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
